Latest posts

  • AmpliTech Reports Second Quarter 2023 Financial Results

    Reports Sales of $4.1 million, $1.9 million Gross Profit, and Record Gross Margin of 47% Company Continues to Invest for Growth HAUPPAUGE, NY, August 14, 2023 – AmpliTech Group, Inc (Nasdaq: AMPG), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, and other communications networks, including the design of complete 5G/6G systems, and

    Read more

  • Oncocyte Reports Second Quarter 2023 Financial Results

    Conference Call on Thursday, August 10, 2023, at 5:00 a.m. PT / 8:00 a.m. ET IRVINE, CA, August 10, 2023 – Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, today reported financial results for the second quarter of 2023, ended June 30, 2023. Second Quarter and Recent Highlights “In the second quarter, we made significant progress

    Read more

  • ONCOCYTE REGAINS COMPLIANCE WITH NASDAQ LISTING REQUIREMENTS

    IRVINE, CA, August 9, 2023 – Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, today announced that it has received written notice from the Listing Qualifications Staff of the Nasdaq Stock Market (“Nasdaq”) stating that the Company has regained compliance with the Nasdaq minimum bid price continued listing requirement and the matter is now closed. The

    Read more

  • Oncocyte to Participate in 8th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference

    CEO Josh Riggs will be meeting with registered investors on Tuesday, August 15, 2023 IRVINE, CA, August 8, 2023 – Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, announced today that it will participate in the 8th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference taking place on August 14-15th, 2023. Josh Riggs, CEO of Oncocyte,

    Read more

  • Oncocyte To Announce Second Quarter 2023 Financial Results

    Conference Call and Webcast on Thursday, August 10, 2023, at 5:00 a.m. PT / 8:00 a.m. ET IRVINE, CA, August 3, 2023 – Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, announced today that it will release its second quarter 2023 financial results on Thursday, August 10, 2023, prior to the U.S. market open. The company

    Read more